Gland Pharma Limited (GLAND.NS) NSE

Currency In INR

AD

Gland Pharma Limited

Address

Plot No. 11 & 84, TSIIC Phase: IV

Hyderabad, 502307

India

Phone

91 84 5569 9999

Sector

Healthcare

Industry

Drug Manufacturers - General

Employees

4217

First IPO Date

November 20, 2020

Key Executives

NameTitlePayYear Born
Shyamakant GiriChief Executive Officer26.06MN/A
Sampath Kumar PallerlamudiCompany Secretary & Vice-President of Compliance & CSR8.12M1981
Ravi Shekhar MitraChief Financial Officer25.65M1977
Srinivas SaduExecutive Chairman86.39M1969
Wriddhee MaitraVice President of Human Resources0N/A
Surinder KoulHead of Domestic Marketing0N/A
Raghuramachandra RaoHead of Quality0N/A
Prasadha Rao LysettiSenior VP & Head of Operations0N/A
Rong WuFinancial Controller0N/A
Shriniwas DangeHead of Investor Relations0N/A
Prabhakara SastryHead of R&D0N/A
AD

Description

Gland Pharma Limited, established in Hyderabad, India, in 1978, is a pharmaceutical company that specializes in the creation, production, and global distribution of generic injectable medications. Its product line features key active pharmaceutical ingredients such as heparin sodium, enoxaparin sodium, rocuronium bromide, and daptomycin injections, among others. The company's extensive therapeutic portfolio encompasses anti-infectives, anesthetics, anticoagulants, antimalarials, cardiovascular drugs, gastrointestinal treatments, pain management, hormones, fertility aids, anti-cancer agents, gynecological remedies, neurological and central nervous system medications, respiratory treatments, blood-related products, ophthalmological and otological solutions, orthopedics, hematinics, and various vitamins, minerals, and nutrients. Additionally, Gland Pharma provides contract development services. The company primarily operates on a business-to-business (B2B) model, distributing its products across major markets including the United States, Europe, Canada, Australia, India, and other international territories. Gland Pharma Limited functions as a subsidiary of Fosun Pharma Industrial Pte. Ltd.

AD